doi: 10.3390/molecules28031344 50 KarstHDroogersWJvan der WeerdNDamsteegtRvan KronenburgNSarabdjitsinghRAet al
Clinical trials have demonstrated remarkable results, with patients achieving weight loss comparable to bariatric surgery outcomes averaging 15-20% total body weight loss without the surgical risks, recovery time, or potential complications
~403 Da (copper complex) Form: Oral capsules Dosage per Capsule: 2mg Capsule Count: 60 capsules per bottle (120mg total) Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Background GHK-Cu has been investigated in research literature across several scientific contexts: Tissue biology research investigations into peptide-copper complex effects on cellular signaling pathways in tissue models Extracellular matrix research studies examining cellular responses involving collagen synthesis pathways and matrix protein regulation in cell culture systems Copper-binding peptide chemistry analytical chemistry research on GHKs selective copper binding properties and the cellular biology of copper homeostasis Cellular signaling pathway research investigations into GHK-Cus interactions with cellular receptor systems and downstream signaling cascades Gene expression research studies examining GHK-Cus effects on cellular gene expression patterns in research models Comparative peptide research analytical studies positioning GHK-Cu alongside other naturally occurring copper-binding peptides in cellular research contexts GHK-Cu is historically significant as one of the most extensively studied naturally occurring copper-binding peptides, originally identified by Pickart et al
Platelet activation, aggregation, and subsequent intra-arterial thrombosis are important steps in atherosclerotic thrombosis, and enhanced platelet reactivity is associated with the degree of terminal organ injury and poor prognosis (73)
Prog Neurobiol 2002;68:377392.ArticlePubMed 17
